Isavuconazole had the lowest hepatotoxicity reporting signal among 5 azole antifungals in the FDA Adverse Event Reporting ...

Data being presented at IDWeek 2026 show zoliflodacin maintains high gonorrhea cure rates in patients co-infected with ...

Today, the Centers for Disease Control and Prevention (CDC) reported there were 4588* cases of measles in the US as of ...

According to the study authors, more than half of children younger than five years living with a person with active hepatitis B virus (HBV) infection were exposed through a househ ...

Olorofim is a first-in-class orotomide antifungal. It selectively inhibits fungal dihydroorotate dehydrogenase, blocking ...

In the phase 3b ENCORE trial, adding amikacin liposome inhalation suspension (ALIS) to azithromycin and ethambutol significantly improved culture conversion in newly diagnosed MAC lung disease, while ...

Oral zelicapavir cut time to complete RSV symptom resolution by up to 1 week in high-risk adults, but it did not meet its ...

Oral pritelivir improved lesion healing and cut hospitalizations from 76% to 29.4% vs investigator's choice therapy in immunocompromised patients with refractory HSV.

The first animal model of neonatal sepsis to evaluate protection by maternal vaccination evidences transfer of immunity against virulent, often antibiotic-resistant Klebseilla pneumoniae.

The FDA approved Hibsago (bepirovirsen; GSK), the first antisense oligonucleotide for chronic hepatitis B, for use with a nucleos (t)ide analogue in adults without cirrhosis, the agency announced ...

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion ...

Guidelines on antiretroviral treatment of HIV issued by the Department of Health and Human Services (HHS) were updated in September to reflect the recent, evidence-based consensus ...